New Tool Uses Deep-Learning AI Technology to Accurately Assess Severity of Lung Infections in COVID-19 Patients
By HospiMedica International staff writers Posted on 04 Jun 2021 |
Image: Chest x-rays used in the COVID-Net study show differing infection extent and opacity in the lungs of COVID-19 patients (Photo courtesy of University of Waterloo)
A new artificial intelligence (AI) technology is capable of assessing the severity of COVID-19 cases with a promising degree of accuracy.
The new work, part of the COVID-Net open-source initiative launched more than a year ago, involved researchers from the University of Waterloo (Waterloo, ON, Canada) and spin-off startup company DarwinAI (Waterloo, ON, Canada). Deep-learning AI was trained to analyze the extent and opacity of infection in the lungs of COVID-19 patients based on chest X-rays. Its scores were then compared to assessments of the same X-rays by expert radiologists.
For both extent and opacity, important indicators of the severity of infections, predictions made by the AI software were in good alignment with scores provided by the human experts. The researchers believe that the technology could give doctors an important tool to help them manage cases.
"Assessing the severity of a patient with COVID-19 is a critical step in the clinical workflow for determining the best course of action for treatment and care, be it admitting the patient to ICU, giving a patient oxygen therapy, or putting a patient on a mechanical ventilator," said Alexander Wong, a systems design engineering professor and co-founder of DarwinAI. "The promising results in this study show that artificial intelligence has a strong potential to be an effective tool for supporting frontline healthcare workers in their decisions and improving clinical efficiency, which is especially important given how much stress the ongoing pandemic has placed on healthcare systems around the world."
Related Links:
University of Waterloo
DarwinAI
The new work, part of the COVID-Net open-source initiative launched more than a year ago, involved researchers from the University of Waterloo (Waterloo, ON, Canada) and spin-off startup company DarwinAI (Waterloo, ON, Canada). Deep-learning AI was trained to analyze the extent and opacity of infection in the lungs of COVID-19 patients based on chest X-rays. Its scores were then compared to assessments of the same X-rays by expert radiologists.
For both extent and opacity, important indicators of the severity of infections, predictions made by the AI software were in good alignment with scores provided by the human experts. The researchers believe that the technology could give doctors an important tool to help them manage cases.
"Assessing the severity of a patient with COVID-19 is a critical step in the clinical workflow for determining the best course of action for treatment and care, be it admitting the patient to ICU, giving a patient oxygen therapy, or putting a patient on a mechanical ventilator," said Alexander Wong, a systems design engineering professor and co-founder of DarwinAI. "The promising results in this study show that artificial intelligence has a strong potential to be an effective tool for supporting frontline healthcare workers in their decisions and improving clinical efficiency, which is especially important given how much stress the ongoing pandemic has placed on healthcare systems around the world."
Related Links:
University of Waterloo
DarwinAI
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans